Genmab A/S - American Depositary Shares — Quarterly Balance Sheet (NASDAQ:GMAB)

Genmab A/S - American Depositary Shares

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

GMAB

Financials

Genmab A/S - American Depositary Shares

Notizie

Guggenheim riduce il target di prezzo del titolo Genmab a 40$ per guidance deboli

Guggenheim cuts Genmab stock price target to $40 on weak guidance

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.08%

3 società sanitarie che potrebbero diventare oro nel primo trimestre - Benzinga Italia

Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Genmab (NASDAQ:GMAB), HealthStream (NASDAQ:HSTM)

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.51%

H.C. Wainwright alza il target su Genmab a $40 per la solidità della pipeline

H.C. Wainwright raises Genmab stock price target to $40 on pipeline strength

Genmab cala del 5% mentre dati contrastanti su Epkinly oscurano solidi risultati FY25

Genmab drops 5% as mixed Epkinly data overshadows solid FY25 beat

Genmab avvia un programma di riacquisto azioni fino a 725 milioni di DKK

Genmab initiates share buy-back program worth up to 725 million DKK